Today: 9 April 2026
Lloyds share price today: LLOY slips ahead of full-year results after sanctions fine
28 January 2026
2 mins read

Lloyds share price today: LLOY slips ahead of full-year results after sanctions fine

London, January 28, 2026, 08:12 GMT — Regular session

Lloyds Banking Group (LLOY.L) shares edged lower in early London trade on Wednesday, falling roughly 0.1% to about 105.1 pence by 0812 GMT. So far, the stock has fluctuated between 104.85 and 105.50 pence during the session. Investing.com

The stock ended Tuesday at 105.25 pence, up 2.2%, hitting a 52-week peak after opening at 103.95 pence, according to data from Stock Analysis. This surge means the shares are now vulnerable to any slip-ups in guidance as earnings season kicks off. StockAnalysis

UK bank shares drove much of the gains in London’s market. The FTSE 100 climbed 0.6% on Tuesday, while the banking index surged 2.4%, hitting its highest point since May 2008. Investors are digesting a packed earnings calendar ahead of the U.S. Federal Reserve’s decision set for Wednesday. Reuters

A minor regulatory setback hit the group when Britain’s Office of Financial Sanctions Implementation fined Lloyds-owned Bank of Scotland £160,000. The penalty came after the bank processed 24 payments totaling around £77,000 connected to a UK-designated person linked to Russia sanctions. Lloyds responded by saying it had “acted swiftly and transparently” and reinforced controls. Reuters

Investors are also eyeing something more optimistic: raised targets. Sources say banks like HSBC, NatWest, Barclays, and Lloyds are expected to lift their profitability goals in upcoming reports. Jefferies analysts suggest Lloyds might set a return on tangible equity (ROTE)—profit relative to shareholder funds minus goodwill—as high as 18.5% by 2028. “UK banks have benefited from earnings resilience lasting longer than initially expected,” noted Peter Rothwell, KPMG UK’s head of banking. At the same time, Shore Capital’s Gary Greenwood cautioned that mounting pressure to increase credit flow could tighten loan pricing. Reuters

Separately, Lloyds is involved in a government-backed scheme aimed at boosting bank lending to exporters. Britain’s top five banks have pledged to provide 11 billion pounds in loans to help businesses grow internationally, with UK Export Finance covering up to 80% of eligible lending, the government announced Monday. Reuters

The macro backdrop is playing its part. The Fed is set to keep rates unchanged on Wednesday, following three cuts late last year. Markets are on edge for any hint of how fast easing might pick up again. Reuters

Lloyds faces a clear focus: interest income, credit losses, and costs. A results preview out Monday flagged net interest income and margins as key areas for investors, alongside any clues on capital returns. Investing.com UK

One recurring headache in UK bank earnings remains motor finance. Lloyds took an 800 million pound hit last year related to this, slashing its guidance as a result. Any sign that the final redress bill is climbing could weigh on plans for capital returns. Reuters

The sanctions fine might be modest in pounds and pence, yet it’s the kind of headline that raises fresh doubts about controls and governance. For a stock perched at a one-year high, that carries weight.

Lloyds will release its preliminary 2025 results on Thursday. CEO Charlie Nunn and CFO William Chalmers are set to present at 0930 GMT, per the group’s financial calendar. Lloyds Banking Group

For now, traders are focused on one straightforward trigger: the line-by-line results — targets, provisions, and any shifts in the medium-term outlook. Thursday is the next key date to watch.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Compass Group share price eyes rebound after sliding to fresh 52-week low
Previous Story

Compass Group share price eyes rebound after sliding to fresh 52-week low

NatWest share price dips as traders weigh possible 2027 profit target lift
Next Story

NatWest share price dips as traders weigh possible 2027 profit target lift

Go toTop